Anti-TNFSF13/APRIL/CD256 Antibody (Sibeprenlimab)
Catalog No.
F1004
Anti-TNFSF13/APRIL/CD256 Antibody (Sibeprenlimab)
Featured Products
Sibeprenlimab (VIS649) is a humanized IgG2 monoclonal antibody that inhibits apoptosis-promoting ligand (APRIL). Sibeprenlimab inhibits pathogenic immunoglobulins (IgA and IgM) while preserving the antibody response to SARS-COV-2 from mRNA-based vaccines. Sibeprenlimab reduces urine protein to creatinine ratio (UPCR) and glomerular filtration rate (GFR). Sibeprelimab has potential for investigational use in IgA nephropathy (IgAN).
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.36 kDa
Dry ice
2382896-07-1
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
VIS 649, VIS649, VIS-649
100 mM Pro 20 mM Arg pH 5.0. No preservative!
O75888
Human
Unconjugated
Monoclonal
Protein A
IgG2SA
ELISA, FACS, Kinetics, Functional assay, Animal Model
TNFSF13 / APRIL / CD256
Please avoid freeze-thaw cycles.